Response to Damning Health Foundation Report
UK | Care England has responded to a damning Health Foundation report, “Poverty, pay and the case for change in social care.” Care England,…
GLOBAL
SMC Upholds Lecanemab Decision
UK | Alzheimer’s Disease International (ADI) has reflected on the decision by the Scottish Medicines Consortium (SMC) not to recommend Lecanemab for treatment. The…
Educating Older Adults About Balanced Nutrition
USA | The National Council on Ageing (NCOA), the national voice for every person’s right to age well, has partnered with BOOST, a leading…
Social Services Aim Shifted
UK | Adult social services advocates say the Government’s aim to shift health and care from hospital to community is in doubt by a…
UK Government Commits to 10-year Plan
UK | The UK Government has published its 10-Year Health Plan for England, outlining shifts in the way the NHS works. Alzheimer’s Society UK…
Watching Closely: UK GOVT Responds to Health and Social Care
UK | Care England said it would be watching the Government closely following reform suggestions by the Health and Social Care Committee Report. Care…
Neighbourhood Health Services a Possibility
UK | Care England said the UK Government’s plan to introduce neighbourhood health services could work if planned appropriately with the best resources. Care…
EMPOWER Health Act Strongly Supported
USA | Introducing the EMPOWER for Health Act has been strongly supported by the American Geriatrics Society, aimed at highlighting education. The American Geriatrics…
Links between Rugby and Dementia
UK | A series of studies has determined the probability of retired professional rugby players developing dementia in later life or other cognitive concerns….
Cleva Card Report Highlights Client Funds Issue
UK | Care England has partnered with Cleva Card to highlight the issue of adult social care management of client funds. A new report…
Care England Welcomes NHS Plan
UK | Care England has welcomed the 10-year plan proposed by the NHS, but said its success hinges on social care leadership and integration….
NHS Rejects Proposed Alzheimer’s Drugs
UK | Donanemab and lecanemab have been advised to not be provided on the NHS by the National Institute for Health and Care Excellence….